Literature DB >> 12450676

Diagnosis and monitoring of inborn errors of metabolism using urease-pretreatment of urine, isotope dilution, and gas chromatography-mass spectrometry.

Tomiko Kuhara1.   

Abstract

To diagnose inborn errors of metabolism, it would be desirable to simultaneously analyze and quantify organic acids, purines, pyrimidines, amino acids, sugars, polyols, and other compounds using a single-step fractionation; unfortunately, no such method currently exists. The present article will be concerned primarily with a practical yet comprehensive diagnostic procedure of inborn errors of metabolism (IEM). This procedure involves the use of urine or eluates from urine on filter paper, stable isotope dilution, and gas chromatography-mass spectrometry (GC-MS). This procedure not only offers reliable and quantitative evidence for diagnosing, understanding and monitoring the diseases, but also provides evidence for the diagnosis of new kinds of IEM. In this review, the differential diagnosis for hyperammonemia are described; deficiencies of ornithine carbamoyl transferase, argininosuccinate synthase (citrullinemia), argininosuccinate lyase and arginase, lysinuric protein intolerance, hyperammonemia-hyperornithinemia-homocitrullinemia syndrome, and citrullinemia type II. The diagnosis of IEM of purine and pyrimidine such as deficiencies of hypoxanthine-guanine phosphoribosyl transferase, adenine phosphoribosyl transferase, dihydropyrimidine dehydrogenase, dihydropyrimidinase and beta-ureidopropionase are described. During the pilot study for newborn screening, we found neonates with diseases at a rate of 1 per 1,400 including propionic acidemia, methylmalonic acidemia, orotic aciduria, beta-ureidopropionase deficiency, lactic aciduria and neuroblastoma. A rapid and reliable prenatal diagnosis for propionic acidemia is also described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450676     DOI: 10.1016/s1570-0232(02)00670-0

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

1.  Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China.

Authors:  Fei Wang; Lianshu Han; Yanling Yang; Xuefan Gu; Jun Ye; Wenjuan Qiu; Huiwen Zhang; Yafen Zhang; Xiaolan Gao; Yu Wang
Journal:  J Inherit Metab Dis       Date:  2010-10-06       Impact factor: 4.982

2.  Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry.

Authors:  Eric Chun Yong Chan; Kishore Kumar Pasikanti; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2011-09-08       Impact factor: 13.491

3.  Development and Validation of a GC-FID Method for Diagnosis of Methylmalonic Acidemia.

Authors:  Fatemeh Keyfi; Abdolreza Varasteh
Journal:  Rep Biochem Mol Biol       Date:  2016-04

4.  A Description of Reference Ranges for Organic Acids in Urine Samples from A Pediatric Population in Iran.

Authors:  Fatemeh Keyfi; Zoltan Lukacs; Abdolreza Varasteh
Journal:  Rep Biochem Mol Biol       Date:  2017-10

5.  Urinary 2-hydroxy-5-oxoproline, the lactam form of α-ketoglutaramate, is markedly increased in urea cycle disorders.

Authors:  Tomiko Kuhara; Yoshito Inoue; Morimasa Ohse; Boris F Krasnikov; Arthur J L Cooper
Journal:  Anal Bioanal Chem       Date:  2011-02-06       Impact factor: 4.142

6.  Novel two-step derivation method for the synchronous analysis of inherited metabolic disorders using urine.

Authors:  Xiao-Qi Sheng; Yi-Chao Wang
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

7.  Mutation analysis of methylmalonyl CoA mutase gene exon 2 in Egyptian families: Identification of 25 novel allelic variants.

Authors:  Dina A Ghoraba; Magdy M Mohammed; Osama K Zaki
Journal:  Meta Gene       Date:  2015-02-25

8.  Metabolic screening and its impact in children with nonsyndromic intellectual disability.

Authors:  Yasser F Ali; Salah El-Morshedy; Riad M Elsayed; Amr M El-Sherbini; Saber Am El-Sayed; Nasser Ismail A Abdelrahman; Abdulbasit Abdulhalim Imam
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-19       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.